Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Olmesartan Medoxomil 40 mg vs Benicar in Fed Healthy Subjects
NCT03319706Phase 1Completed
- Sponsor
- Torrent Pharmaceuticals Limited
- Start
- Aug 2010
- Primary completion
- Sep 2010
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of olmesartan in hypertension (HTN) (2 arms), sponsored by Torrent Pharmaceuticals Limited. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve. Started Aug 2010; status: completed.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03319706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03319706.